Lili Feng

6.4k total citations · 3 hit papers
67 papers, 5.2k citations indexed

About

Lili Feng is a scholar working on Molecular Biology, Nephrology and Immunology. According to data from OpenAlex, Lili Feng has authored 67 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 10 papers in Nephrology and 10 papers in Immunology. Recurrent topics in Lili Feng's work include Gout, Hyperuricemia, Uric Acid (5 papers), Microbial Metabolic Engineering and Bioproduction (4 papers) and Renal Diseases and Glomerulopathies (4 papers). Lili Feng is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (5 papers), Microbial Metabolic Engineering and Bioproduction (4 papers) and Renal Diseases and Glomerulopathies (4 papers). Lili Feng collaborates with scholars based in China, United States and Japan. Lili Feng's co-authors include Richard J. Johnson, Takahiko Nakagawa, Duk‐Hee Kang, Susumu Watanabe, Marilda Mazzali, Lin Han, Luan D. Truong, Jiahuai Han, Richard J. Ulevitch and Yong Jiang and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Blood.

In The Last Decade

Lili Feng

64 papers receiving 5.1k citations

Hit Papers

A Role for Uric Acid in the Progression of Renal Disease 2002 2026 2010 2018 2002 2002 2007 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lili Feng China 25 2.1k 2.0k 1.1k 896 787 67 5.2k
Fuyou Liu China 40 2.3k 1.1× 2.6k 1.3× 651 0.6× 873 1.0× 693 0.9× 206 6.2k
Wilfred Lieberthal United States 41 1.7k 0.8× 2.4k 1.2× 871 0.8× 592 0.7× 909 1.2× 79 5.9k
Chengyuan Tang China 39 1.8k 0.8× 2.9k 1.4× 925 0.8× 1.5k 1.7× 507 0.6× 100 6.1k
Shougang Zhuang United States 53 2.4k 1.1× 4.8k 2.3× 857 0.8× 831 0.9× 960 1.2× 213 9.0k
Takaharu Ichimura United States 32 2.6k 1.2× 2.0k 1.0× 584 0.5× 480 0.5× 1.1k 1.4× 62 6.1k
Hunjoo Ha South Korea 49 2.0k 0.9× 2.8k 1.4× 519 0.5× 801 0.9× 1.2k 1.5× 167 7.8k
Mary E. Choi United States 41 1.2k 0.6× 2.9k 1.4× 399 0.4× 1.3k 1.4× 470 0.6× 73 5.6k
Niansong Wang China 38 1.6k 0.7× 1.9k 0.9× 389 0.4× 514 0.6× 583 0.7× 193 4.6k
Nimesh S. A. Patel United Kingdom 41 901 0.4× 1.5k 0.7× 541 0.5× 440 0.5× 604 0.8× 84 4.6k
Yoshitsugu Takabatake Japan 33 1.3k 0.6× 1.4k 0.7× 541 0.5× 1.5k 1.7× 433 0.6× 71 4.1k

Countries citing papers authored by Lili Feng

Since Specialization
Citations

This map shows the geographic impact of Lili Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lili Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lili Feng more than expected).

Fields of papers citing papers by Lili Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lili Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lili Feng. The network helps show where Lili Feng may publish in the future.

Co-authorship network of co-authors of Lili Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Lili Feng. A scholar is included among the top collaborators of Lili Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lili Feng. Lili Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Hao, Peng Wang, Long Li, et al.. (2025). Ferrostatin-1 mitigates acute lung injury by reducing ferroptosis levels in gas explosions. Tissue and Cell. 94. 102773–102773.
2.
Li, Jialin, et al.. (2025). Magnesium-based nanomaterials for cancer therapy: Unraveling mechanisms and current developments. Coordination Chemistry Reviews. 547. 217119–217119.
3.
Zou, Xuan, Yi Ouyang, Yu Wu, et al.. (2024). AI-Driven Diagnostic Assistance in Medical Inquiry: Reinforcement Learning Algorithm Development and Validation. Journal of Medical Internet Research. 26. e54616–e54616. 9 indexed citations
4.
Lu, Ya-Ping, Ya-Ping Lu, Xiang Chen, et al.. (2023). Endothelial TFEB signaling-mediated autophagic disturbance initiates microglial activation and cognitive dysfunction. Autophagy. 19(6). 1803–1820. 18 indexed citations
6.
Feng, Lili, Yanfen Cui, Zhenhui Li, et al.. (2023). An MRI-based scoring system for pretreatment risk stratification in locally advanced rectal cancer. British Journal of Cancer. 129(7). 1095–1104. 9 indexed citations
7.
Horimoto, Katsuhisa, Tadamasa Sasaki, Kazuhiko Fukui, et al.. (2023). Phosphorylated protein chip combined with artificial intelligence tools for precise drug screening. Journal of Biomedical Research. 38(3). 195–195. 1 indexed citations
8.
Feng, Lili, et al.. (2022). Multilevel regulation of N6-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities. Genes & Diseases. 10(5). 1969–1981. 3 indexed citations
9.
Feng, Lili, et al.. (2019). Novel mutations and the ophthalmologic characters in Chinese patients with Wolfram Syndrome. Orphanet Journal of Rare Diseases. 14(1). 190–190. 6 indexed citations
10.
Sun, Yaning, Jifei Yang, Suzhen Yang, et al.. (2018). Development of an immunochromatographic lateral flow strip for the simultaneous detection of aminoglycoside residues in milk. RSC Advances. 8(17). 9580–9586. 29 indexed citations
11.
Chen, Tao, et al.. (2017). Enhancement of 5-aminolevulinic acid production by metabolic engineering of the glycine biosynthesis pathway in Corynebacterium glutamicum. Biotechnology Letters. 39(9). 1369–1374. 16 indexed citations
12.
Liu, Hailiang, Rui Xu, Lili Feng, et al.. (2012). A Novel Chromone Derivative with Anti-Inflammatory Property via Inhibition of ROS-Dependent Activation of TRAF6-ASK1-p38 Pathway. PLoS ONE. 7(8). e37168–e37168. 40 indexed citations
13.
Feng, Lili, Xuefeng Wu, Hailiang Liu, et al.. (2012). Vaticaffinol, a resveratrol tetramer, exerts more preferable immunosuppressive activity than its precursor in vitro and in vivo through multiple aspects against activated T lymphocytes. Toxicology and Applied Pharmacology. 267(2). 167–173. 8 indexed citations
14.
Kang, Duk‐Hee, Lin Han, Xiaosen Ouyang, et al.. (2005). Uric Acid Causes Vascular Smooth Muscle Cell Proliferation by Entering Cells via a Functional Urate Transporter. American Journal of Nephrology. 25(5). 425–433. 189 indexed citations
15.
Long, David A., Mohammad Newaz, Sharma Prabhakar, et al.. (2005). Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging. Kidney International. 68(5). 2154–2163. 51 indexed citations
16.
Kang, Duk‐Hee, Takahiko Nakagawa, Lili Feng, et al.. (2002). A Role for Uric Acid in the Progression of Renal Disease. Journal of the American Society of Nephrology. 13(12). 2888–2897. 1075 indexed citations breakdown →
17.
Feng, Lili, et al.. (1998). Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis. Developmental Dynamics. 213(1). 121–129. 39 indexed citations
18.
Jiang, Yong, Hermann Gram, Ming Zhao, et al.. (1997). Characterization of the Structure and Function of the Fourth Member of p38 Group Mitogen-activated Protein Kinases, p38δ. Journal of Biological Chemistry. 272(48). 30122–30128. 412 indexed citations
19.
Salafranca, Mina N., et al.. (1996). Identification of Two Rat Genes Orthologous to the Human Interleukin-8 Receptors. Journal of Biological Chemistry. 271(51). 32770–32776. 65 indexed citations
20.
Ye, Richard D., Vladimir V. Kravchenko, Zhixing K. Pan, & Lili Feng. (1996). Stimulation of NF-κB Activation and Gene Expression by Platelet-Activating Factor. Advances in experimental medicine and biology. 416. 143–151. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026